R.E.M.S. technology reaches the oceanic continent.
We are proud to announce the achievement of sales authorization for the Echolight products issued by the Australia Government Department of Health. So Australia is also opening its doors to R.E.M.S. (Radiofrequency Echographic Multi Spectrometry) bringing the presence of Echolight to over 40 countries around the world.
R.E.M.S. is the innovative technology running the operation of the EchoS densitometer which performs in a few minutes an ultrasound scan of the bone without radiation, delivers the report in real time being able to check the bone health status and then reduce the risk of fragility fracture, as a consequence of osteoporosis.
Being now used in hundreds of hospitals and clinical centers around the world, the device is also available in Australia thanks to the collaboration with an important local partner with the purpose of introducing a new concept of bone health, based on prevention, early diagnosis and bone structure monitoring
REMS protagonista nel Master dell’Università LUM
La School of Management dell’Università LUM lancia il Master in “Management Clinico e Diagnostica Strumentale dell'Osteoporosi e Malattie del Metabolismo Osseo” con Focus sulla Tecnologia REMS La School of Management dell’Università LUM, la più importante e...
Echolight all’audizione del Consiglio Regionale Pugliese
L’Osteoporosi costa alla Puglia 42 milioni l’anno per i soli ricoveri per fratture Il Consiglio regionale pugliese ha audito la Prof.ssa Maria Luisa Brandi (Endocrinologa) e il Prof. Biagio Moretti (Ortopedico) sulle recenti Linee guida del Ministero della...
Echolight & IOF
Echolight entra a far parte del Committee of Corporate Advisor della IOF (International Osteoporosis Foundation) (Lecce, Settembre 2023): Siamo lieti di informarvi che Echolight è entrata ufficialmente a far parte del Comitato dei Consulenti Aziendali (CCA) della IOF...